Kaul urges CDC to clarify classification of PrEP
Attorney General Josh Kaul urged the Centers for Disease Control and Prevention last week for clear classification of PrEP, an HIV prevention drug, to avoid improperly charged medical copays.
To access this content, you must purchase a Premium membership, or log in if you are a member.
